Large scale safety study of a liquid hexavalent vaccine (D-T-acP–IPV–PRP∼T–HBs) administered at 2, 4, 6 and 12–14 months of age
- 12 November 2001
- Vol. 20 (3-4) , 448-454
- https://doi.org/10.1016/s0264-410x(01)00344-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infantsThe Pediatric Infectious Disease Journal, 2000
- Extensive Swelling After Booster Doses of Acellular Pertussis–Tetanus–Diphtheria VaccinesPediatrics, 2000
- Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussisThe Lancet, 1999
- Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of ageThe Pediatric Infectious Disease Journal, 1998
- Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infantsThe Pediatric Infectious Disease Journal, 1998
- Efficacy of a two-component acellular pertussis vaccine in infantsThe Pediatric Infectious Disease Journal, 1997
- Clinical Comparison of the Haemophilus influenzae Type B Polysaccharide-Diphtheria Toxoid and the Oligosaccharide–CRM197 Protein Vaccines in InfancyArchives of Pediatrics & Adolescent Medicine, 1994
- Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccineThe Pediatric Infectious Disease Journal, 1994
- The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of ageThe Pediatric Infectious Disease Journal, 1991
- Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infantsThe Pediatric Infectious Disease Journal, 1991